Tech Company Financing Transactions
Commit Biologics Funding Round
Commit Biologics secured a $60 million Seed funding round on 11/17/2026. Investors included Ackermans & Van Haaren, AbbVie Biotech Ventures and Bioqube Ventures.
Transaction Overview
Company Name
Announced On
11/17/2026
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds for the completion of IND-enabling activities and IND filing for COM002, and advancement of a second program into IND-enabling development and expand Commit's BiCE� pipeline.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Universitetsbyen 83
Aarhus C, 8000
Denmark
Aarhus C, 8000
Denmark
Phone
Website
Email Address
Overview
Founded in 2021, Commit Biologics is a biotech spin-out from Aarhus University in Denmark -- an academic institution with a global reputation in complement system biology from more than three decades of complement research. The Commit team combines expertise in antibody development and complement research to develop a new type of therapeutics to treat cancer and autoimmune diseases.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 11/17/2026: Noeri venture capital transaction
Next: 11/17/2026: Vision Makers venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








